Secretory immunoglobulin A (sIgA) is the dominant immW1oglobulin in human milk, and apart from the obvious contribution it makes towards the protection of the infant, sIgA may also form an important part of the defense of the mammary gland. This report involves a mother (M8) who participated in a research study investigating the relationships between symptoms and changes in the physiology of the lactating breast during mastitis. Breastmilk samples were collected on Days 14, 30, 60, and 90 postpartum, to establish the normal reference range of biochemical markers, and during periods of breast inflammation. M8 experienced seven episod es of blocked duct(s) during the first 19 weeks, five of which occurred within the 90-day reference sample collection period. On analysis, it was found there was no detectable sIgA present in her milk samples. Medical referral and further testing resulted in a diagnosis of selective IgA deficiency, of which the mother had not been previously aware. M8 showed little variation in her milk composition even when suffering with blocked duct(s), although there was an increase in the concentration of lactoferrin in both breasts at reference collection days 14-90. Lactoferrin concentration was also W1usually high at Day 14 (15 gi L) in the left breast and continued to be increased in this breast until Day 60. The absence of s lgA in this mother's breastmilk may have been a contributing factor in her experiencing recurren t blocked ducts.
Introduction

S ECRIITORY IMMUNOGLOBULIN ([g) A (s[gA) is the dominant
[g in human milk with a concentra tion in colostrum of approximately 10 gi L, which decreases rapidly to 1-2 gi L by the end of the first week after birth.] It is a polymeric mo[-ecule composed of two (or more) ' gA monomers, a J chain, and a secretory component. The important contribution that s lgA makes towards the protection of the neonate is well known!; however, it also forms an important part of the defense against pathogens that colonize and invade all body surfaces that <He bathed in secretions. It functions by neutralizing bacteri al enzymes and toxins and inhibiting bacterial adhesion through the prevention of both nonspecific and s tereochemical inte ractions. It is also though t to act synergistically with innate immune factors present in secretions such as lactoferrin, lac toperoxidase, a nd mucins. 3 Al though there is a paucity of literature s pecificall y regarding the role of s lgA in defense of the mammary gland, there is an abundance of research regarding its effects on the limitation of bacterial adherence in buccal, intestinal, urinary, genital, nasal, and bronchial epithelia . 3 The importance of the [gA system in protection of the mammary gland is implicated in resea rch involving the s timulation of loca l immunity in a variety of animals with differing 'gA milk levels. The production of local antibodies in the mammary glands of animals infused with antigens was much greater and persisted longer in animals that previously had higher levels of milk IgA.4 in women, s lgA, in conjunction with lactoferrin and complement 3, was significantl y lower in the milk of Gambian women who later developed mastitis. s These findings were maintained even when analysis was adjusted fo r stage of lactation, season, ;md parity.
IgA deficiency is defined as either primary or secondary in etiology. Secondary deficiency may be related to a range lSchool of Nursing, Murdoch Universi ty, Ma ndllfah, WA, Australia. 2School of Biomedical. Biomolecular, and Chemical Sciences, The University of Western A u~tralia, Crawley, W A. A ustralia.
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of factors, such as drugs and infections (e.g., rubella, cytomegloviruses, Epstein-Barr virus). A lthough [gA deficiency is generally considered permanent, occasionally there is spontaneous remission, for instance, when the causal medication is ceased. 6 Several physiological variables, such as psychological s tress, intense endurance exercise, and sleep deprivation, have been a&sociated with decreased concentra tions of slgA in saliva, where the concentration of salivary slgA was inversely related to the level of psychological stress experienced?,R As an increased level of stress has been found to be a risk factor for masti tis in mul tiparous women who are breastfeeding. 9 it is possible there may be a relationship among increased level$ of $tress, lower level$ of slgA in brea$tmilk, and $usceptibi lity to ma$titi$. However, thi$ is not supported by a study tha t found slgA in breast milk w as posi tively correlated to stress in mothers, where stress was assessed using Cohen's Perceived Stress Scale. tO Selective IgA deficiency is the most common form of primary immunodeficiency, with a re ported frequency of 1:500 in the Caucasiiln populiltion.ll Filctors ilssociil ted with the prevalence of selective ' gA deficiency include a family history and the coun try of origin. [n particular, selective [gA deficiency varies signi ficantly across differing ethnic groups where, among hea lthy blood donor$, the prevalence has been re ported as ranging from one in 328-633 for those of European ancestry to one in 5,000 in Ch ina and one in 18,500 in Japan. 12 Caution in the interpretation of some of these findings has been recommended because of the variation in definitions used in some diagnostic testing. I ! Most laboratories now define the adult reference range as 0.8-4.0 giL, w here deficiency in IgA is defined as < 0.07 g/L, which is the concentration below w hich nephelometry (the routine commercia l labora tory test used for [gs) becomes unreliable.!3
Case Report
This report involves a mother (M8), a Caucasian, 33-yearold p rimipara, who participated in a research study investigating the relationships between clinical descriptors and changes in the physiology of the lactating breast during mastitis.14-16 ' n brief, the study required samples of milk from both breasts and 24-hour urine samples to be collected on Days 5, 14, 30, 60, and 90 postpartum and blood to be collected on Days 5 and 14, to establish the norma l reference range of biochemical markers for each individual participant in the cohort. Breastmilk samples were hand-expressed, and a single blood sample was taken at a point during the 24-hour urine colk>etion that was convenient for the mother. Mil k samples were analyzed for sodium (Na), chloride (CI), lactose, glucose, C-reactive protein (CRP), slgA, lactoferrin, and serum albumin. Urine samples were analyzed for lactose, and blood samples were assayed for lactose and CRP. When women reported inflammatory breast symptoms the resea rcher visited them in their home daily and again at follow-up, 7 days after resolution of symptoms. During these visits samples of blood, milk from the affected and contralateral breasts, and 24-hour urine specimens were collected. Mothers were interviewed at reference and mastitis time points to establish the presence of any co-existing illness and breast pathology. Hypothesis testing of all outcome measures was based on analyses of variance with repeilted
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measures. All analyses were adjusted for stage of lactation and co-existing breast and systemic pathologies.
Inflammation of the breast during lactation is experienced in differing degrees of severity, and no t all episodes of breast inflammation are classified as mastitis. Clinically, mi lder cases of focal inflilmmation that arc not accompanied by systemic illness arc traditionally diagnosed as blocked duct(s). 17 Often these episodes arc manifested by a localized area of erythema and tenderness that may be accompanied by a nodular lumpiness on palpation and usua lly respond to the conservative management of increased frequency of breastfeeding and massage of the affected area. 17 Blocked duct(s), fo r the purpose of this study, were defined as localized inflammatory breast symptoms tha t were present for less than 24 hours with no accompanying systemic symptoms. Localized inflammatory breast symptoms were defined as either focal erythema or tenderness/ pain that mayor may not be associated with a nodular lumpiness on palpation. During the study period there were 13 episodes of blocked ducts experienced by eight mothers. Eleven of the episodes were accompanied by co-existing pathologies. Three mothers experiencing only one episode each of blocked duct(s) also su ffered with either nipp!e trauma (/1 = 2) or perceived oversupply (/I = 1). Two mothers had diagnosed medical diso rders: Hashimoto's thyroiditis and 'gA deficiency. The mother with Hashimoto's thyroiditis (M21) experienced four episodes of mastitis late in her lactation (behveen Day 280 and Day 400) and one episode of blocked duct(s) (Day 310) during a period of significant personal stress. The mean concentration of slgA in her breastmilk during the 9O-day reference sample collection period (0.91 + 0.15 g/L) was already significantly lower (t22 = 4.9, P < 0.001) than tha t of the other asymptomatic mothers in the study cohort (1.1 + 0.5 giL). The mother (MS) with IgA deficiency is the subject of this case re port, and she experienced seven of the 13 observed episodes of blocked duct(s) within the first 19 weeks postpartum.
Results
Despi te five of the seven recurrent episodes of blocked duct(s) occurring during the 9O-day reference sample collection period, M8 was asymptomatic at each of the routine reference collection days. On analysis, there was no detectable slgA (d etection limit, > 0.09 g/ L) present in any of her milk samples. As a result, her Day 14 blood sample was sent to an independent commercial laboratory where IgA, IgG, and IgM in blood were analyzed. Normal ranges at this laboratory were stated as follows: IgA, 0.69-3.1 giL; IgG, 6.1 -13 g/L; and IgM, 0.53-3.32 giLlS The results for MS were < 0.0667, 11.3, and 2.92 g/L, respecti vely, and she was subsequently referred for medica l assessment where a diagnosis of selective 19A deficiency was made. M8 had not been previously investigated or diagnosed with 'gA deficiency, although s he reported multiple and rec urrent e pisodes of sinorespiratory and ear infections as a child, for which surgical interventions were required.
Unfortunately M8 was not recruited into the study un til Day 7 postpartum, so there are no Day 5 reference sample resu lts ava ilable. Components in the rema ining four reference sample collections at Days 14-90 postpartum remained within the normal range for the study cohort,14 with the ex-
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n>plion of lactaferrin. The concentration of laclaferrin w as very high (15 giL) in her left breast al Day 14 compared to those mothers with asymptomatic breasts (3.8 + 2.9 giL), ilnd it remained slightly above the asymp tomiltic mean for the remaining reference sample collections a t Days 30, 60, and 90 postpartum (Fig. 1) . The increased concentration of lactoferrin in milk on Day 14 was associated wi th an elevated serum eR r of 102 mg/L (where the normal eRr in blood is < 10 mg/L). There was no evidence of either systemic infection or localized inflammation; however, M8 had experienced a 12-hour labor with no progression of cervical dilatation and meconium-stained liquor and had therefore undergone a nonelective Caesarean section. CRP in milk w as undetected, and urinary lactose excretion (4.7 mmol/24 hours) was just outside the normal range for OilY 14 (3.4 + l.l mmol/24 hours), perhaps indicating a s light increilse in breas t pcrmeilbility.1 5 MS experienced recurren t blocked duct(s) at Days 35, 36, 65,68,72, 114, and 133 postpartum. Episodes were experienced in differing locations of both the right (II = 4) and left (/I = 3) breasts (Fig. 1) . Management consisted of frequen t feeding, offering the affected breast first, and milssage of the ilffected areil, resul ting in resolution of symptoms by 24 hours. The only obvious changes tha t occurred in her milk composition we re during episodes experienced at Day 36 and Day 133. During the Day 36 e pisode both the concentration of Na (12 mmol/L) and Cl (25 mmol/L) in milk from the affeded breast were ra ised, although they did not exceed the norma l range fro m asymptomiltic breasts in the s tudy.14 Mil k lac tose from the a ffected breast (176 mmol/L) was within no rmal range; however, the excretion of lactose in urine was increased (S mmol/24 hours). During the Day 133 e pisode, the conce n trations of Na (11 mmol/L) and C! (23 mmol/ L) were again raised compared to her reference mean (S.l and 19.6 mmol/L, respectively), this time in association w it h a decrease in the concentration of lactose (139 mmol/ L) and glucose (0.94 mmol/L). A 24-hour urine specimen was not collected. There were no significant changes in mil k composition observed in the remaining five episodes. The lack of change was congruent with the resul ts from the other women with blocked d uct(s) whose milk composition and lactose excretion were wi thin normal range for the study sample.1~
Discussion
Blocked duct(s) are a commonly reported problem among breastfeeding women, and although each episode is generally tra nsient some women can be plagued with many recurrences throughout their lac tation. Reassuringly, unlike in mastitis, changes in breastmil k composi tion arc often either absent or short-lived and of little signi ficance,14 as WilS the case with MS. During five of the seven episodes of blocked duct(s) her milk compositio n was within the normal range for the s tudy sample and did not vary greatly from he r own asymptomatic reference samples. The variabi lity in milk lactose and the excretion of lactose in urine during the remaining two episodes can perhaps be explained in terms of the differing physiological stages experienced from onset th rough to recovery of the blocked duct(s) and the timing of the milk and 24-hour urine sample collections. As episodes of blocked d ucts arc generally of short dura tion, timing of a single milk sample collt.'Ction may be crucial to the changes observed, especia lly in relation to the more encompassing 24-hour urine sample. Changes in milk composition indicative of an increase in paracellular pa thway permeabili ty may not be observed as milk from the blocked area may not be able to be expressed. The resul ting sample, as on the Day 36 episode, would reflec t milk expressed from nonaffected areas of the breast and thus appear within the normal range. However, the concurrent increased excretion of lactose in urine indicates there was an increase in breast permeability nol detectable in the mi lk expressed for analysis, which most likely only occurred al the affe<:ted site. In conlrasllo the majority of thc episodes of blocked duct(s) thc low lactose and glucose concentrations o n Day 133 reflect both an increase in breast permeabil ity and a dl><:rease in lactose synthcsis. 14 . 1S
The transient na ture of some episodes of breast inflammation and the lack of certainty in being able to express milk from an area of inflammation, where the duct may be blocked, provide possible explanations for other unusual observatio ns such as those in one study where a normal Na/K ratio was found even in the presence of observable breast inflammation and a raised tumo r necrosis factor-alpha level in milk.I 9 It remains uncertain as to whether the absence of s lgA in the milk o f M8 was a major contribu ting faelor fo r her experiencing rl-'<:urrent blocked duct(s). As s lgA is a n ,mti-adht.'Slve mo!e<:ule, a deficiency of this Ig ma y have increased the likelihood o f bacterial adhesion within the breast, ca using local inflammation tha t was overcome with more frequent feeding and the subsequent increased flushing o f milk. The recurrent nature o f the problem is su ggesti ve of a susceptibility of the breast to inflammation tha t may be related to the absence of IgA and is supported by another study where women who d eveloped mastitis had lower levels of s lgA in thei r milk than the normal population. s
The only other mother in t he study with a d iagnosed medical condi ti on (M21 ) was taking thyroxine replacement therapy for Hashimoto's thyroiditis, an autoimmu ne disease charaelerized by dest ru ction of thyroid cells by various cell and an ti body-mediated immune processes. 20 This mother experienced one episode o f blocked duct(s) and four episodes o f masti tis during this lactation and also reported a history of multiple recurre nt episodes of mastitis wi th each of her previous three lactations. Although thyroiditis is one of a number of specific disorders associa ted with IgA deficiency, this was not the case with M21. However, she w a s observed to have significantl y lower concentra tions o f s lgA in her breast milk during the 9O-day reference collection period, lendi ng support to an association among low s lgA in brea stmilk, increased stress, and susceptibi lity to breast inf1ammation. S , 8.9.21 The remaining e p isodes of blocked d ucl(s) detected during the study were associated wi th nipple trauma and oversupply, both conditions having been previously id entified as pred isposing factors for masti tis .17.22
The increased concentra tions of lactoferrin in the milk of M8, particularly in the first 2 weeks postpartum, are of inte rest. There is evidence tha t slgA aels synergisti cal! y both to enhance the bacteriostatic effect o f laeloferrin by increasing lactoferrin's sequestration of iron from microorganisms and by binding to lactoferrin, enabling the protein to target microorganisms. 3 The increase in lacloferrin in the absence of s lgA may be suggestive of a compensatory effect. Variable patterns of compensatory incre<lses o f IgG and IgM antibodies have been reported in the mi lk from three women wi th IgA deficiency.23 Al though such analyses were not obtained fo r the milk from M8, her serum IgG and Ig M WeTI' found to be at the higher end of the normal range. The as-5()ciated high concentratio n of CRr in blood appears not to have been re lated to the breast as there was no obvious breast inflamma tion, although there was a very slight increase in urinary laelose excretion. This may be related to the increased CRr a s increased breast permeability during lacta-
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ti on has been associa ted wi th acute system ic illness in the absence of obvious breast in fl ammation. 24 
Conclusions
As IgA deficiency has a high incidence in Caucasian populations it may be of value to consider investigating furth er those mothers with either recurrent blocked ducts or mastitis who also re port a history suggestive of 19A deficiency, such as recurrent ink'<:tions, drug allergy, o r autoimmune or atopic disease.
